MannKind | Capital Social E Reservas

Equity Capital And Reserves Alterar Data
Adma Biologics USD 153.71M 18.5M 2024-03
Dynavax Technologies USD 618.48M 3.59M 2024-03
Eli Lilly USD 12.9B 1.68B 2024-03
Halozyme Therapeutics USD 177.81M 94M 2024-03
Insmed USD -464808000 132.88M 2024-03
MacroGenics USD 106.15M 46.46M 2024-03
MannKind USD -229970000 16.2M 2024-03
Merck USD 40.42B 822M 2024-03
Novo Nordisk DKK 98.91B 7.65B 2024-03
Pfizer USD 92.56B 4.38B 2024-03
Xencor USD 612.19M 56.61M 2024-03



MannKind Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.